How Is Sjogren's Disease Diagnosed?
If you’re trying to figure out whether your symptoms could be Sjogren’s disease, you may quickly discover that getting a clear answer isn’t always simple.
There is no single test that can diagnose—or completely rule out—Sjogren’s disease in every person.
Instead, doctors may use a combination of your medical history and symptoms, blood tests, a detailed dry-eye evaluation, measurements of saliva production, salivary gland imaging and, in some cases, a minor salivary gland biopsy.
That distinction matters. You can have negative bloodwork and still require further evaluation for Sjogren’s. You can have dry eyes without having Sjogren’s. You can have a positive autoimmune antibody without that antibody alone establishing a diagnosis.
Sjogren's diagnosis is about looking at the whole clinical picture.
What Tests Are Used to Diagnose Sjogren’s Disease?
There isn’t one universal testing pathway that every person will follow. Depending on your symptoms and findings, a Sjogren’s evaluation may include medical history and symptom evaluation; SSA/Ro and SSB/La antibody testing; ANA, rheumatoid factor and other laboratory testing; Ro52 and Ro60 antibody testing; comprehensive dry-eye evaluation; Schirmer testing; ocular surface staining; salivary-flow testing; salivary gland ultrasound; minor salivary gland, or lip, biopsy; and additional or emerging tests in certain situations, including AVISE CTD or an Early Sjogren’s Panel.
Not every person needs every test. The goal is to determine whether the evidence, taken together, supports Sjogren’s disease and whether another condition could better explain the symptoms.
What Blood Tests Are Used for Sjogren’s Disease?
Bloodwork is often one of the first things people encounter during a Sjogren’s evaluation.
SSA/Ro and SSB/La
One of the most important antibodies associated with Sjogren’s is anti-SSA/Ro. Anti-SSA/Ro is also one of the five objective findings included in the current 2016 ACR/EULAR classification criteria. A positive SSA/Ro receives three points within that classification system.
You may also be tested for anti-SSB/La. SSB/La can provide useful information as part of an autoimmune evaluation, but isolated SSB/La positivity is not one of the weighted items in the current classification criteria.
What Are Ro52 and Ro60?
If you look closely at your bloodwork, you may encounter the names Ro52 and Ro60. These are distinct proteins associated with the broader SSA/Ro antibody system. Depending on the laboratory and testing method, Ro52 and Ro60 antibodies may be tested or reported differently.
They are not simply two different names for the exact same antibody, and these antibodies can occur in Sjogren’s as well as other autoimmune and connective tissue diseases. If your results mention Ro52 or Ro60, it can be useful to ask exactly which antibodies were tested and how the laboratory reported them.
What Other Bloodwork Might Be Ordered?
Depending on your symptoms and medical history, your healthcare provider may also look at ANA, rheumatoid factor, a complete blood count, metabolic testing, inflammatory markers, immunoglobulins and complement levels such as C3 and C4. These tests may provide additional information about autoimmune activity or other possible explanations for your symptoms, but none of them by itself is “the Sjogren’s test.”
Can You Have Sjogren’s With Negative Bloodwork?
Yes. Some people with Sjogren’s do not have detectable SSA/Ro antibodies. You may hear these patients described as having seronegative Sjogren’s disease.
Seronegative does not mean that symptoms are insignificant. It means the traditional antibody evidence may not be there, making the other pieces of the evaluation particularly important.
If your SSA/Ro is negative but your symptoms and clinical history continue to raise concern for Sjogren’s, your healthcare provider may consider other objective evidence rather than relying on bloodwork alone. That might include eye findings, saliva production, salivary gland evaluation or, when appropriate, a minor salivary gland biopsy.
What Is the AVISE Test for Sjogren’s?
Some people undergoing an autoimmune workup encounter AVISE CTD, a commercial blood-testing panel designed to assist clinicians evaluating connective tissue and autoimmune diseases. The Sjogren’s portion can provide additional antibody information, including testing related to SSA/Ro and SSB/La.
AVISE should be understood as additional information within an autoimmune evaluation, not as a standalone test that independently proves or excludes Sjogren’s disease. Your healthcare provider still needs to interpret the results alongside your symptoms, examination and other objective findings.
What Is the Early Sjogren’s Panel?
You may also hear about an Early Sjogren’s Panel. These panels can include antibodies against SP1 (Salivary Protein 1), CA6 (Carbonic Anhydrase VI) and PSP (Parotid Secretory Protein). Researchers have investigated whether these antibodies could provide additional information, particularly in people who do not have traditional Sjogren’s antibodies.
SP1, CA6 and PSP are not currently part of the 2016 ACR/EULAR Sjogren’s classification criteria, and their role in routine clinical diagnosis remains uncertain.
Studies have produced mixed findings, and research continues into their usefulness. A positive Early Sjogren’s Panel should therefore not automatically be interpreted as a Sjogren’s diagnosis—and a negative one does not automatically exclude the disease.
What Eye Tests Are Used for Sjogren’s Disease?
If Sjogren’s is suspected, a comprehensive dry-eye evaluation can provide important objective evidence.
A routine eye examination is not necessarily the same thing as a Sjogren’s-focused dry-eye evaluation.
Schirmer Test
The Schirmer test measures tear production. Small strips of special paper are placed along the lower eyelids, and tear production is measured over five minutes. Under the current classification criteria, a result of 5 mm or less in five minutes in at least one eye receives one point. An abnormal Schirmer test alone, however, does not diagnose Sjogren’s.
Ocular Surface Staining
An eye-care professional may also use special dyes to examine the surface of the eye. This allows the clinician to identify and score damage to the ocular surface. An ocular staining score meeting the specified threshold is another of the five objective findings included in the 2016 classification criteria.
Other Dry-Eye Testing
A comprehensive dry-eye evaluation may include additional testing, such as evaluation of the tear film and tear-film break-up time. These findings can help an eye-care professional understand what is happening on the surface of your eyes even though every dry-eye test is not part of the formal Sjogren’s classification criteria.
A test can provide useful clinical information without being one of the formal classification criteria.
How Is Saliva Production Tested?
Doctors can objectively measure how much saliva you produce. One method is called unstimulated whole salivary flow testing, or sialometry. Under the current classification criteria, an unstimulated whole salivary flow rate of 0.1 mL per minute or less receives one point.
Reduced saliva production does not automatically mean Sjogren’s. Medications and other medical conditions can also contribute to dry mouth. Again, context matters.
Can Salivary Gland Ultrasound Help Diagnose Sjogren’s?
Salivary gland ultrasound, often abbreviated SGUS, gives clinicians a noninvasive way to examine the major salivary glands, particularly the parotid and submandibular glands. Doctors can look for structural changes within the glands that may provide additional evidence when Sjogren’s is suspected.
Salivary gland ultrasound is particularly interesting because it does not require surgery or radiation and is being actively studied as Sjogren’s diagnostic approaches continue to evolve.
Salivary gland ultrasound is not currently one of the five items included in the 2016 ACR/EULAR classification criteria.
Although SGUS may provide valuable information in an individual evaluation, it should not currently be described as a universal replacement for other established testing.
What Is a Lip Biopsy for Sjogren’s?
A minor salivary gland biopsy, commonly called a lip biopsy, can provide another important piece of objective evidence. During the procedure, small salivary glands are removed from inside the lower lip and examined under a microscope.
The pathologist looks for a characteristic pattern of inflammation called focal lymphocytic sialadenitis and calculates a focus score. Under the 2016 classification criteria, focal lymphocytic sialadenitis with a focus score of at least 1 focus per 4 mm² receives three points—the same number of points given for positive SSA/Ro antibodies.
That can make biopsy particularly important to discuss when someone has negative SSA/Ro testing but there is still significant clinical suspicion for Sjogren’s. It is also important that biopsy collection and interpretation are done appropriately.
Not everyone being evaluated for Sjogren’s needs a lip biopsy. Whether its potential value outweighs the downsides of an invasive procedure is an individual conversation with your healthcare team.
What Are the Sjogren’s Classification Criteria?
The 2016 ACR/EULAR classification criteria use five weighted objective findings: anti-SSA/Ro positivity — 3 points; a qualifying minor salivary gland biopsy — 3 points; a qualifying ocular staining score — 1 point; a Schirmer result of 5 mm or less over five minutes — 1 point; and an unstimulated whole salivary flow rate of 0.1 mL per minute or less — 1 point.
For an appropriate patient, a total score of 4 or more meets the 2016 ACR/EULAR classification criteria.
But there is an extremely important word in that sentence: classification.
Classification Criteria Are Not the Same as Clinical Diagnosis
The 2016 ACR/EULAR criteria were developed and validated as classification criteria, including for identifying sufficiently uniform groups of patients for research and clinical trials. The original paper describes them as well suited for clinical-trial enrollment.
That is different from saying that if you don’t reach four points, you cannot possibly have Sjogren’s disease. Clinical diagnosis involves the physician evaluating the individual patient—not simply plugging numbers into a scoring system.
Objective findings remain extremely important. But understanding the difference between classification and diagnosis can help patients have more informed conversations about what their test results actually mean.
Who Diagnoses Sjogren’s Disease?
A rheumatologist commonly plays a central role in diagnosing and managing Sjogren’s disease, but several specialists may contribute important pieces of the evaluation. An ophthalmologist or optometrist may document objective dry-eye findings. A dentist or oral-medicine specialist may identify significant oral dryness or its complications. An ENT or other experienced clinician may be involved in salivary gland evaluation or biopsy. A neurologist may become involved when neurological symptoms are prominent. Other specialists may be needed depending on which organs or body systems are affected.
This multidisciplinary aspect of Sjogren’s is another reason diagnosis can sometimes feel fragmented. One doctor sees your eyes. Another sees your mouth. Another evaluates your joint pain, fatigue or neurological symptoms.
Someone still has to connect those pieces.
What If All My Sjogren’s Tests Are Negative?
Negative testing matters. It should not simply be dismissed. But the next step is understanding what was actually tested and what the results do—and do not—tell you.
If your evaluation does not support Sjogren’s, your healthcare provider should also consider other explanations for your symptoms. But if significant symptoms continue without an explanation, reasonable questions might include: Have I had only bloodwork, or have I had objective eye and salivary testing too? Was SSA/Ro actually tested, and do I know how it was reported? Have other possible causes of my symptoms been considered? Given my complete clinical picture, is additional evaluation appropriate?
The goal should not be to force every unexplained symptom into a Sjogren’s diagnosis.
The goal is to make sure the investigation is thorough enough to find the best explanation possible.
Questions to Ask When You’re Being Evaluated for Sjogren’s
You don’t need to walk into your appointment and tell your doctor which tests to order. But understanding the process can help you ask better questions.
Consider asking: Which Sjogren’s antibodies have actually been tested? Do my results include SSA/Ro, and were Ro52 and Ro60 reported separately? If my antibodies are negative, what other objective testing might be appropriate based on my symptoms? Have I had a comprehensive dry-eye evaluation or only a routine eye exam? Would salivary-flow testing provide useful information? Is salivary gland ultrasound available or appropriate for me? Under what circumstances would you consider a minor salivary gland biopsy? Are you using the ACR/EULAR criteria as classification criteria or as the sole basis for determining whether Sjogren’s is possible? What other conditions could explain the symptoms I’m experiencing?
You don’t have to ask every question. Choose the ones that fit your situation.
The Most Important Thing to Remember About Sjogren’s Diagnosis
If you take one thing away from this article, let it be this: There isn’t one “Sjogren’s test.”
Diagnosis may involve bloodwork, eye testing, salivary testing, imaging, biopsy and—most importantly—someone looking at your complete clinical picture.
One result may provide an important clue. Another may be negative. And sometimes the next step is simply figuring out which pieces of the puzzle haven’t been evaluated yet.
You do not have to diagnose yourself. But you can learn enough about Sjogren’s to understand your testing, keep track of your symptoms and ask informed questions about what should happen next.
I spent a long time learning how to connect the dots in my own healthcare. Once I learned how important those dots could be, I decided I wasn’t going to keep the map to myself.
That’s a big part of why Sjogren’s with Jody exists.
If you’re trying to connect the dots between your symptoms, testing and the questions you want to bring to your healthcare team, you’ll find more education, resources and support throughout this site and inside Jody’s Waiting Room.
Frequently Asked Questions About Sjogren’s Diagnosis
Is there one definitive test for Sjogren’s disease?
No. Sjogren’s is generally evaluated using a combination of symptoms, medical history, bloodwork and objective tests involving the eyes and salivary glands. Some people may also undergo a minor salivary gland biopsy.
Can I have Sjogren’s if my SSA is negative?
Yes. Negative SSA/Ro testing does not by itself exclude Sjogren’s disease. Additional objective testing may be considered when the clinical picture continues to raise suspicion.
Does a positive ANA mean I have Sjogren’s?
No. ANA can occur in Sjogren’s and many other autoimmune conditions, and it can also be positive in some people who do not have an autoimmune disease. It has to be interpreted within the larger clinical picture.
Does a positive Early Sjogren’s Panel mean I have Sjogren’s?
Not necessarily. SP1, CA6 and PSP antibodies remain an evolving area of research and are not currently included in the ACR/EULAR classification criteria.
Do I need a lip biopsy to be diagnosed with Sjogren’s?
Not everyone does. A lip biopsy can provide valuable objective evidence, particularly in certain seronegative or diagnostically unclear cases, but whether one is appropriate depends on the individual situation.
Can a salivary gland ultrasound diagnose Sjogren’s?
Salivary gland ultrasound can provide useful information about structural changes in the major salivary glands, but it is not currently one of the five weighted items in the 2016 ACR/EULAR classification criteria.
DISCLAIMER: This article is for educational purposes only and is not medical advice. Testing and diagnosis should be discussed with your healthcare provider.
I had negative lip biopsy some positive labs and a pouch biopsy for small fiber neuropathy after a decade of symptoms!
Dawn, after a decade of symptoms, I can only imagine how frustrating that journey has been. One thing I always try to emphasize is that a negative lip biopsy doesn’t automatically rule out Sjogren’s disease, especially when other clinical findings support the possibility. I’m curious about your positive labs and whether your biopsy confirmed small fiber neuropathy. Have you received a Sjogren’s diagnosis, or are you still searching for answers? 💙
After a decade of symptoms, I can only imagine how frustrating and exhausting that diagnostic journey has been. One thing I think is important for people to understand is that a negative lip biopsy doesn’t necessarily rule out Sjogren’s disease. The results need to be considered alongside blood work, symptoms, and other clinical findings. Small fiber neuropathy can also be associated with Sjogren’s disease, although it has other possible causes. Your experience is a good reminder of why looking at the entire clinical picture matters so much. Thank you for sharing your story here.
Can someone on immunoglobulin treatment be harder to diagnose with Sjogrens i have cll , cvid, glild, and now they are testing for sjogrens .
That’s a really good question, especially when you’re already managing several immune-related conditions. Immunoglobulin replacement therapy, such as IVIG or SCIG, can sometimes affect the interpretation of certain antibody blood tests because these treatments contain antibodies from donors. However, that doesn’t mean Sjogren’s disease can’t be diagnosed. Blood work is only one part of the evaluation. Objective dry eye testing, salivary gland testing, and sometimes a lip biopsy can also help. The important thing is that your healthcare team considers your immunoglobulin treatment when interpreting your results. I hope this helps clarify things a little.